D.J. Franks

1.1k total citations
28 papers, 888 citations indexed

About

D.J. Franks is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, D.J. Franks has authored 28 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Pharmacology. Recurrent topics in D.J. Franks's work include Diabetes Treatment and Management (4 papers), Cell death mechanisms and regulation (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). D.J. Franks is often cited by papers focused on Diabetes Treatment and Management (4 papers), Cell death mechanisms and regulation (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). D.J. Franks collaborates with scholars based in Canada, United Kingdom and United States. D.J. Franks's co-authors include John P. MacManus, Pavel Hamet, T. Youdale, J. F. Whitfield, B. Braceland, David F. Horrobin, M.S. Manku, Josée Plamondon, Maura Simboli-Campbell and AnneMarie Gagnon and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Circulation Research.

In The Last Decade

D.J. Franks

28 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.J. Franks Canada 15 431 150 111 108 92 28 888
Douglas J. Franks Canada 15 473 1.1× 112 0.7× 144 1.3× 82 0.8× 61 0.7× 31 793
Kathryn E. Kronquist United States 15 675 1.6× 135 0.9× 58 0.5× 97 0.9× 77 0.8× 20 987
A.J. Aarsman Netherlands 16 614 1.4× 169 1.1× 99 0.9× 128 1.2× 73 0.8× 22 1.0k
Yoshiharu Kikawa Japan 15 555 1.3× 235 1.6× 58 0.5× 105 1.0× 182 2.0× 51 1.1k
Tomas Welbourne United States 19 592 1.4× 224 1.5× 182 1.6× 113 1.0× 56 0.6× 49 1.4k
J H Gronich United States 7 490 1.1× 144 1.0× 48 0.4× 51 0.5× 70 0.8× 7 723
P H Figard United States 17 498 1.2× 179 1.2× 101 0.9× 126 1.2× 123 1.3× 22 1.1k
JC Fruchart France 6 580 1.3× 165 1.1× 75 0.7× 100 0.9× 117 1.3× 9 896
J.W.N. Akkerman Netherlands 18 408 0.9× 110 0.7× 45 0.4× 84 0.8× 46 0.5× 35 904
H. Mutoh Japan 13 346 0.8× 112 0.7× 47 0.4× 192 1.8× 53 0.6× 24 800

Countries citing papers authored by D.J. Franks

Since Specialization
Citations

This map shows the geographic impact of D.J. Franks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.J. Franks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.J. Franks more than expected).

Fields of papers citing papers by D.J. Franks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.J. Franks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.J. Franks. The network helps show where D.J. Franks may publish in the future.

Co-authorship network of co-authors of D.J. Franks

This figure shows the co-authorship network connecting the top 25 collaborators of D.J. Franks. A scholar is included among the top collaborators of D.J. Franks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.J. Franks. D.J. Franks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Charokopou, M., Lucy A. Eddowes, Mark D. Griffiths, et al.. (2014). Cost-Effectiveness of Dapagliflozin Versus Dpp-4 Inhibitors as Monotherapy in the Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective. Value in Health. 17(7). A347–A347. 1 indexed citations
3.
4.
5.
Ryan, Scott D., et al.. (2004). Anti-apoptotic Actions of the Platelet-activating Factor Acetylhydrolase I α2 Catalytic Subunit. Journal of Biological Chemistry. 279(50). 52425–52436. 39 indexed citations
6.
Imbeault, Sophie, et al.. (2002). Platelet activating factor‐induced apoptosis is inhibited by ectopic expression of the platelet activating factor G‐protein coupled receptor. Journal of Neurochemistry. 82(6). 1502–1511. 26 indexed citations
7.
Simboli-Campbell, Maura, AnneMarie Gagnon, D.J. Franks, & JoEllen Welsh. (1994). 1,25-Dihydroxyvitamin D3 translocates protein kinase C beta to nucleus and enhances plasma membrane association of protein kinase C alpha in renal epithelial cells.. Journal of Biological Chemistry. 269(5). 3257–3264. 56 indexed citations
8.
Miller, M.M., et al.. (1994). Modulation of a renal estrogen receptor by protein kinase C.. PubMed. 2(1). 33–40. 5 indexed citations
9.
Cadrin, Monique, Norma McFarlane‐Anderson, Hiromu Kawahara, et al.. (1992). Differential phosphorylation of CK8 and CK18 by 12-O-tetradecanoyl-phorbol-13-acetate in primary cultures of mouse hepatocytes. Cellular Signalling. 4(6). 715–722. 18 indexed citations
10.
Durkin, Jon P., Balu Chakravarthy, Geoffrey Mealing, et al.. (1990). The role of signal-transducing events in the proliferative response of cells to a mitogenic viral K-ras protein. Cellular Signalling. 2(3). 285–297. 3 indexed citations
11.
Durkin, Jon P., Balu Chakravarthy, D.J. Franks, et al.. (1988). Early Cellular Responses to the Activation of a Mitogenic/Oncogenic Viral K‐RAS Protein. Annals of the New York Academy of Sciences. 551(1). 186–200. 1 indexed citations
12.
Franks, D.J., Josée Plamondon, & Pavel Hamet. (1984). An increase in adenylate cyclase activity precedes DNA synthesis in cultured vascular smooth muscle cells. Journal of Cellular Physiology. 119(1). 41–45. 60 indexed citations
13.
Hamet, Pavel, et al.. (1978). Cyclic nucleotides and aggregation in platelets of spontaneously hypertensive rats.. Circulation Research. 43(4). 583–591. 39 indexed citations
14.
Termijtelen, A., et al.. (1977). Interpretation of data obtained from primed lymphocyte tests (PLTs).. PubMed. 9(1). 421–4. 14 indexed citations
15.
Horrobin, David F., M.S. Manku, D.J. Franks, & Pavel Hamet. (1977). Methyl xanthine phosphodiesterase inhibitors behave as prostaglandin antagonists in a perfused rat mesenteric artery preparation. Prostaglandins. 13(1). 33–40. 83 indexed citations
16.
MacManus, John P., D.J. Franks, T. Youdale, & B. Braceland. (1972). Increases in rat liver cyclic AMP concentrations prior to the initiation of DNA synthesis following partial hepatectomy or hormone infusion. Biochemical and Biophysical Research Communications. 49(5). 1201–1207. 145 indexed citations
17.
Whitfield, J. F., John P. MacManus, T. Youdale, & D.J. Franks. (1971). The roles of calcium and cyclic AMP in the stimulatory action of parathyroid hormone on thymic lymphocyte proliferation. Journal of Cellular Physiology. 78(3). 355–368. 83 indexed citations
18.
Whitfield, J. F., John P. MacManus, D.J. Franks, Douglas J. Gillan, & T. Youdale. (1971). The Possible Mediation by Cyclic AMP of the Stimulation of Thymocyte Proliferation by Cyclic GMP. Experimental Biology and Medicine. 137(2). 453–457. 31 indexed citations
19.
Franks, D.J., John P. MacManus, & J. F. Whitfield. (1971). The effect of prostaglandins on cyclic AMP production and cell proliferation in thymic lymphocytes. Biochemical and Biophysical Research Communications. 44(5). 1177–1183. 79 indexed citations
20.
Franks, D.J. & David A. Stansfield. (1970). Studies on adenyl cyclase and adenosine triphosphatase in rat corpus luteum. Biochemical Journal. 117(2). 25P–26P. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas J. Franks Breakdown of academic impact, for papers by Kathryn E. Kronquist Breakdown of academic impact, for papers by A.J. Aarsman Breakdown of academic impact, for papers by Yoshiharu Kikawa Breakdown of academic impact, for papers by Tomas Welbourne Breakdown of academic impact, for papers by J H Gronich Breakdown of academic impact, for papers by P H Figard Breakdown of academic impact, for papers by JC Fruchart Breakdown of academic impact, for papers by J.W.N. Akkerman Breakdown of academic impact, for papers by H. Mutoh
Rankless by CCL
2026